New drug trial offers hope for patients with advanced cancers out of options
NCT ID NCT04478279
Summary
This early-stage study is testing a new drug called ST101 in patients with advanced solid tumors that cannot be surgically removed and have spread. The trial aims to find a safe and effective dose for cancers including glioblastoma, melanoma, breast cancer, and prostate cancer in people who have already tried and stopped responding to standard treatments. Researchers will first test increasing doses to check safety, then expand to specific cancer groups to see if the drug helps control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University
New York, New York, 10032, United States
-
Duke University School of Medicine
Durham, North Carolina, 27708, United States
-
Edinburgh Cancer Centre
Edinburgh, EH4 2SP, United Kingdom
-
Northwestern Medicine Cancer Centers
Warrenville, Illinois, 60555, United States
-
START Midwest
Grand Rapids, Michigan, 49503, United States
-
Sarah Cannon Research Institute
Denver, Colorado, 80218, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Sarah Cannon Research Institute UK
London, W1G 6AD, United Kingdom
-
The Beaston West of Scotland Cancer Centre
Glasgow, G12 0YN, United Kingdom
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Leeds
Leeds, LS9 7TF, United Kingdom
Conditions
Explore the condition pages connected to this study.